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MELITTIN, the predominant fraction of bee venom pro-
teins, was studied in an experimental model of human
neutrophil granulocytes to reveal its influence on eicosa-
noid release, metabolism and receptor function in relation
to intracellular calcium metabolism. Melittin (2 pmol/1)
was as potent as the calcium ionophore A23187 (10 pmol/l)
for activation of 5-1ipoxygenase, releasing arachidonate
only from phosphatidyl-choline and phosphatidyl-ethano-
lamine of cellular membranes, as judged from the de-
creases in radioactivity by 15.4% and 30.5%, respectively.
The mechanism responsible for the release ofarachidonate
from cellular membranes is closely coupled to cellular
calcium metabolism, and melittin was found to promote
calcium entry through receptor gated calcium channels,
probably due to an activation of phospholipase A2. Fur-
thermore, a down-regulation of leukotriene B4 receptors
was seen. The maximal number of binding sites per cell
was reduced from a median of 1520 to 950 with melittin
(1 p moll1). The study has revealed some factors important
for the inflammatory mechanisms mediated by melittin.
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Introduction
Melittin is a polypeptide toxin which constitutes
more than 50% of bee venom proteins. It has been
claimed to release endogenous arachidonic acid
(AA) from cultured cells and to increase formation
of prostanoids through activation of membrane
bound enzymes.
2-4 Further, melittin was found to
be able to stimulate exogenous non-incorporated
AA metabolism in human polymorphonuclear
neutrophils (PMN), and recent research has dealt
with the interaction between melittin and cellular
membranes.
6
The aims of the present work were: (1) to assess
if melittin was a stimulator of endogenous AA
metabolism in purified human PMNs; (2) to
compare its potency with that of the calcium
ionophore A23187; (3) to reveal where in the
phospholipid pool AA was mobilized by melittin
challenge; (4) to evaluate its influence on cellular
calcium metabolism; and finally (5) to investigate
its possible action on surface leukotriene B4
receptors.
Materials and Methods
In six experiments neutrophils were isolated from
EDTA-blood (0.2 mmol/1), with a recovery of 45%,
and a purity of more than 95%, by: (1)
methylcellulose (0.8%) sedimentation of ery-
throcytes; (2) washing and gradient centrifugation
of’buffy coat’ leukocytes according to B6yum;
7 and
finally (3) hypotonic lysis of residual erythrocytes.
Incorporation of 1-14C-AA (37 x 103 Bq/ml, 2.2 x
109 Bq/mmol) (Amersham International, UK) with
labelling of intracellular pools of phospholipids
proceeded for 5 h at 37C under 5% carbon dioxide
and 95% atmospheric air in RPMI 1640 (5 x 106
cells) (5% autologous serum).
8 After removal of
excess extracellular AA by washing, the cells were
challenged with melittin (0.05-10#mol/1) for
various lengths of time (Sigma Chemical Co., St
Louis, MO, USA) or calcium ionophore A23187
(Calbiochem, ta Jolla, CA, USA) (10 #mol/1) for
15 min, which was found to be optimal from
previous experiments.
8 Released eicosanoids were
extracted with dichloromethane:methanol, 2:1;
separated by thin layer chromatography, devel-
oping solvents 1: (supernatants), chloroform:
methanol: acetic acid: water, 90:9:1:0.65; 2: (total
cell suspensions), dichloromethane:methanol: 2-
propanol, 0.25% KC1: ethylacetate, 30:9: 25: 6:18;
and quantified by autoradiography and laser
densitometry.
8
Identification of the radioactive spots was
performed by co-chromatography with pure
standards of phospholipids (Sigma Chemical Co.),
5-hydroxyeicosatetraenoic acid (5-HETE), leuko-
triene B4 (LTB4) (Paesel Gmbh, Frankfurt am Main,
Germany, and 12-hydroxy-heptadecatrienoic acid
(HHT) (Upjohn Company, Kalamazoo, MI, USA).
Further identification was performed by high-
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performance liquid chromatography (HPLC) as
earlier described.
8 The intra-assay coefficient of
variation for release of AA metabolites was
approximately 15%.
8
The viability of the PMNs were assessed by the
trypan blue exclusion technique. In six separate
experiments PMNs (5 x 106/ml) were incubated
with Fura-2/am (Sigma Chemical Co.) (2/tmol/1) for
15 min. The cells were centrifuged, washed twice,
and resuspended. Fluorescence was recorded with
a Hitachi 4000 fluorescence spectrophotometer. For
the calibration of Fura-2 fluorescence as a function
of (Ca2+)i we used digitonin (10 mg/ml) to obtain
a maximum fluorescence signal, Frnax followed by
the addition of EGTA for determination of Frnin.
Intermediate values for Ga
g+ corresponding to an
intracellular Fura-2 fluorescence, F, were calculated
by the equation: Ga
g+ Kd (F Fmin/Frnax P),
assuming an effective Kd of 224nmol/1.
9
N-formylmethionine-leucyl-phenylalanine (fMLP)
(Sigma Chemical Co.) was used in the concentration
range 10 x 10-9--10
-6 mol/1.
In separate receptor studies duplicate suspensions
of PMNs (107/ml) were incubated with radioactive
3H-LTB4 (specific activity 6.3-8.5 x 103 GBq/
mmol, Amersham International, UK), 0.1 nmol/1-
2.5 nmol/1 at 4C for 60 min. Following incuba-
tion, the ceils were rapidly centrifuged through a
precooled oil phase.
9 The tips of the tubes were cut
off, and cell bound radioactivity was determined in
a tracer analytical scintillation counter with an
automatic quench correction. Nonspecific binding
was determined by adding a 1000-fold excess of
non-radioactive LTB4 (Paesel Gmbh, Germany).
1
In specific experiments, 1/tmol/1 melittin was
added to the cell suspensions at 37C for 5 min. The
cells were then rapidly cooled to 4C and binding
experiments were done. For estimation of the
dissociation constant (Kd) and receptor number per
cell (Brnax) a Scatchard plot was applied.
11
Results
Potential sources of arachidonic acid: Optimal conditions
for AA release and metabolism were 2/mol/1
melittin (Table 1) for 10min (Fig. 1), which
resulted in the median release of 415 Bq/5 x 106
PMNs (range 289-618) compared to 670 Bq/5 106
PMNs (range 260-990) for A23187 (p < 0.05).
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FIG. 1. Time course experiments for stimulation of 1-14C-arachidonic
acid labelled neutrophils with melittin (2/mol/I). Values are given as
medians with ranges for six experiments.
The radioactivity, when challenged with melittin
(2/mol/1, 10 min) or A23187 (10/.tmol/1, 15 min),
was distributed on eicosanoids and unmetabolized
AA, as seen in Table 2. No significant differences
occurred.
The substrate for formation of most of the AA
following melittin stimulation was mobilized from
phosphatidyl-choline (PC) and phosphatidyl-etha-
nolamine (PE), owing to the relative decreases in
median radioactivity by 15.4% (p < 0.01), and
30.5% (p < 0.01), respectively (Fig. 2). No
significant changes were found for phosphatidyl-
inositol (PI) or phosphatidyl-serine (PS).
Calcium mobilization" Addition of melittin to PMNs
caused a dose-related increase in intracellular Ca2+
(Ca2+)i concentrations (Fig. 3). This rise was
Table 1. Dose response for release of radioactivity (eicosanoids and unmetabolized arachidonic acid)
by melittin (15 min stimulation period) (n 6). Values for optimal stimulation was taken to 100%
(equal to 415 Bq/5 x 106 PMNs). Medians with 95% confidence limits on medians are given
Concentration of 0.05 0.1 0.5 2 5 10
melittin (/mol/I)
Radioactivity 46 48 52 77 100 68 74
(41-49) (46-51) (49-55) (72-80) (93-107) (64-71) (69-77)
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Table 2. Percentage distribution of radioactivity on eicosanoids
and unmetabolized arachidonic acid after stimulation with
melittin (2 #mol/I, 10 min) or A23187 (10 #mol/I, 15 min).
(n 6). Medians and ranges are given
Arachidonic acid 5-HETE LTB, HHT
Melittin 68.1
(63.7-76.7)
A23187 67.0
(56.2-80.4)
13.5 5.8 1.7
(11.3-14.7) (1.5-6.8) (1.4-2.4)
14.9 5.3 2.2
(9.5-19.4) (2.8-9.6)(1.0-5.3)
abolished in Ca2+-free media, suggesting that a
rnelittin-induced increase in (Ca2+)i) was mediated
by an increase of the plasma membrane permeability
to Ca
2 +.
The characteristics of the calcium signal (time
courses of changes in (Ca2+)i) generated upon
activation of phospholipase A2 (PLAi):(rnelittin)
and phospholipase C (PLC): (LTB4 and fMLP) of
human PMNs are shown in Fig. 4. As can be
seen from this figure the Ca2+ response pattern is
similar after addition of LTB4 or fMLP. This
response is transient, as the rise in (Ca2+)i in the
bulk cytosol is due to a release of Ca+ from
intracellular stores. With melittin, however, the
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FIG. 3. Release of radioactivity (eicosanoids and unmetabolized
arachidonic acid) --O (median values) and change in intracellular free
Ca2/ [(Ca2/)i] ---) (median values and ranges) in human neutrophil
granulocytes by the stimulation with melittin.
Ca2+ rise shows a sustained phase which is due to
influx of Ca
2+ across the plasma membrane, and the
effect is sustained as long as melittin is present in
the medium. Validation of these results is supported
by the experiments performed in a cae+-free
medium (Fig. 5). When extracellular Ga
g+ was
removed, the melittin-induced Ca2+-influx was
inhibited (Fig. 5). However, in a Cai+-free
medium, LTB4 and fMLP still result in a transient
rise in free (Ca2+)i (data not shown).
However, in a cae+-free medium, if melittin is
added before LTB4, the increase in cytosolic free
calcium elicited by LTB4 is completely inhibited
(Fig, 5). To obtain a rise in cytosolic free Ca2+,
a higher concentration (50-fold) of LTB4 is needed.
Further, the Ca2+ rise (Ca
2+ release from
PC PS PI PE
FIG. 2. Change in relative distribution of arachidonic acid in the different
phospholipid fractions after stimulation with melittin (2 #mol/I, 10 rain).
Phosphatidyl-choline (PC), phosphatidyl-serine (PS), phosphatidyl-
inositole (PI), and phosphatidyl-ethanolamine (PE). Values are given as
medians with ranges (bars) for six experiments. *p < 0.01.
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FIG. 4. Time-course changes in fura-2 fluorescence and (Ca2+)i in
human PMNs following addition of LTB (3 x 10-1mol/I), fMLP
(0.1 x 10-6 mol/I), and melittin (3.5 x 10-6 mol/I). Typical trace of five
experiments.
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FIG. 5. Influence of melittin (1 #mol/I) on (Ca2+)i after stimulation of
human PMNs with LTB, (10 nmol/I) or fMLP (10-40 nmol/I) in calcium
free medium.
intracellular stores) induced by fMLP is unaffected
by melittin.
To investigate whether inhibition of the Ca
p.+
signal by LTB4 paralleled a decrease in the number
or affinity of LTB4 receptors, receptor ligand
binding assay experiments were performed.
Figure 6 demonstrates specific binding (a) of
LTB4 and the corresponding Scatchard plot, and
(b) when PMNs were incubated with 3H-LTB4
0.1-2.5 nmol/1. The nonspecific binding was linear
with increasing ligand concentration. From the
Scatchard plot it can be derived that the Kd is
approximately the same, 0.95nmol/1 and 1.05
nmol/1 in cell suspensions with and without melittin
(1/imol/1), respectively. However, melittin sig-
nificantly reduced the maximal number of LTB4
binding sites per cell (Bmax) from 1520 to 950 under
identical experimental conditions.
The viability of the PMNs after challenge with
melittin or A23187 in the concentration ranges used
was more than 97% as assessed by the trypan blue
exclusion technique.
Discussion
The data demonstrate that the bee venom
polypeptide, melittin, is a potent stimulator of
endogenous AA metabolism to mono- and
di-hydroxy products, including LTB4, in human
PMNs which are of importance for inflammatory
reactions. 12’13 Its potency regarding phospholipases
stimulation in human PMNs is about 2/3 that of
A23187, which is assumed to produce a maximal
stimulation of phospholipases and synthesis of
leukotrienes in response to calcium influx. How-
ever, regarding 5-1ipoxygenase stimulation, an
enzyme which has been shown to exhibit an
absolute requirement of calcium ions,
14 melittin and
A23187 were equipotent, as evaluated from the
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FIG. 6. Specific binding (a) and Scatchard plot (b) of neutrophils
(107 ml) incubated with 3H-LTB4 (0.1-2.5 nmol/I) with (O)" melittin
(1 /lmol/I) or (0) without melittin.
relative distribution of the eicosanoids LTB4 and
5-HETE. The characteristic responses of the PMNs
to LTB4, resemble those of the primary stimulus,
fMLP, in the ability to promote a rapid
accumulation of inositol trisphosphate (IP3) and
calcium mobilization through the phospholipase C
system.
1s-iv Further, melittin stimulates cycloox-
ygenase, as evaluated from the production ofHHT,
with a similar potency as found for A23187.
Stimulation of PLA2 as well as PLC, which are
essential for AA metabolism and which have been
demonstrated in PMN membranes,
18 appears to
involve cellular calium.
19 Increase in (Ca2+)i could
be effected either by PLC mediated IP3 accumula-
tion, or by Ca
2 influx through receptor operated
(voltage independent) Ca2+ channels. If calcium
dependent phospholipases are regulators of AA
release, then agents that stimulate PLA2 might be
expected to increase calcium availability. Melittin
has earlier been described to stimulate phospholi-
pase A2 in human leukocytes in the presence of
316 Mediators of Inflammation. Vol 1992Melittin and inflammatory factors
exogenous AA, and an ability to alter membrane
permeability to calcium has been further suggested,
The calcium antagonists, verapamil and nifedipine,
at concentrations known to block classical voltage
dependent calcium channels, had no effect on the
Ca+ influx induced by melittin, possibly due to
receptor operated Ca2+ influx. 9 This is contrary to
apamin, another toxin from bee venom, which
affects the calcium channel function.
6 The possi-
bility that melittin interferes with calcium influx via
secondary messengers (i.e. IP3) is out of question,
since there was no increase in (gag+)i in calcium-free
media. Further, melittin only released AA from PC
and PE and not via the classical way, which
involves PI, PE, PC as the three sources of AA. 19
It has been described earlier, that AA is mobilized
from PC, PE, and PI using the calcium ionophore
A23187.
8
The present investigation has demonstrated that
melittin increases the plasma permeability to
calcium, and that cytosolic free Ca2+ is closely
coupled to melittin induced activation of PLA2.
Further, melittin affects PMN surface LTB4
receptors, as it significantly reduces the maximal
number of LTB4 binding sites per cell (Bmax). One
possible explanation is that melittin generates LTB4
from PMNs. 5 LTB4 is then exported to the
extracellular medium where it subsequently acts as
a receptor agonist on the PMN surfaces with a
resulting down-regulation of LTB4 receptors.
Another explanation is that activators of protein
kinase C (PKC), an important component of the
signal transduction pathway in human PMNs, cause
cells to become unresponsive to LTB4, but not to
fMLP.2 However, in this respect melittin has earlier
been found to be a PKC inhibitor.21 Therefore
melittin may act indirectly as an activator of PKC
through AA release.
22 The latter (AA) is known to
induce diacylglycerol (DAG) generation, which
then activates PKC.
23 Since the production of AA
is high following addition of melittin, we believe
that bee venom via DAG is an indirect
PKC-activator. This could explain the deactivation
and the decrease in the expression ofLTB4 receptors
found in the present study, as explained above.2’23
In conclusion, melittin is a potent challenger of
5-1ipoxygenase AA metabolism in human PMNs.
Its potency regarding phospholipases stimulation is
about 2/3 that of A23187 which is assumed to
produce a maximal stimulation in response to
calcium influx. Further, melittin mobilizes AA from
PC and PE, whereas P1 and PS seem to be
unaffected, and melittin promotes Ca2+ entry
through receptor gated Ca2+-channels, probably
due to a direct activation of phospholipase A2.
Receptor studies indicate that melittin further
affects the total number of LTB4-receptors, either
by a down-regulatory mechanism or via the PKC
system. The present data provide evidence for the
complicated mechanism of melittin, and its
sensitivity to arachidonate metabolism, cellular
eicosanoid receptors and intracellular calcium
suggests that these factors may play a role for the
inflammation mediated by melittin.
References
1. Habermann E. Bee and wasp Science 1972; 177: 314-322.
2. Shier WT. Activation of high levels of endogenous phospholipase A2 in
cultured cells. Proc NatlAcad Sci USA 1979; 76: 195-199.
3. Hojvat SA, Musch MW, Miller RJ. Stimulation of prostaglandin production
in rabbit ileal by bradykinin. J Pharmacol Exp Ther 1983; 226:
749-755.
4. Mauer P, Moskowitz MA, Levine L, Melamed E. The synthesis of
prostaglandins by bovine cerebral microvessels. Prostaglandins Med 1980; 4:
153-161.
5. Salari H, Braquet P, Borgeat P. Stimulation oflipoxygenase product synthesis
in human leukocytes and platelets by melittin. Mol Pharmaco] 1985; 28:
546-548.
6. Hamilton SL, Perez M. Toxins that affect voltage-dependent calcium
channels. Biochem Pharmacol 1987; 36: 3325-3329.
7. B6yum A. Isolation of leucocytes from human blood. Scand J Clin Lab
Invest 1968; 21 (suppl 97): 9-29.
8. Nielsen OH, Bukhave K, Ahnfelt-R#nne I, Elmgreen J. Arachidonic acid
metabolism in human neutrophils: lack of effect of cyclosporine A. Int J
Immunopharmacol 1986; 8: 419-426.
9. Bouchelouche PN, Hainau B, Frederiksen O. Effect of BAY K8644
cytosolic free calcium in isolated rabbit gall-bladder epithelial cells. Cell
Calcium 1989; 10: 37-46.
10. Bouchelouche PN, Berild D. Possible existence of leukotriene D receptors
and mechanism of their signal transduction in human polymorphonuclear
leukocytes. ScandJ Clin Lab Invest 1991; 51 (suppl 204): 47-55.
11. Scatchard G. The attractions of proteins for small molecules and ions. Ann
NY Acad Sci 1949; 51: 660-672.
12. Nielsen OH. In vitro studies on the significance of arachidonate metabolism
and other oxidative processes in the inflammatory response of human
neutrophils and macrophages--with special reference to chronic infl-
ammatory bowel disease. Scand J Gastroentero11988; 23 (suppl 150): 1-21.
13. Naccache PH, Sha’afi RI. Arachidonic acid, leukotriene B4, and neutrophil
activation. Ann NYAcad Sci 1983; 414: 125-139.
14. Rouzer CA, Shimizu T, Samuelsson B. On the nature of the 5-1ipoxygenase
reaction in human leukocytes: characterization of membrane associated
stimulatory factor. Proc NatlAcad Sci USA 1985; 82: 7505-7509.
15. Bradford PG, Rubin RP. Characterization of formylmethionyl-leucyl-
phenylalanine stimulation of inositol trisphosphate accumulation in rabbit
neutrophils. Mol Pharmacol 1985; 27: 74-78.
16. Goldman DW, Grifford LA, Olson DM, Goetzl EJ. Transduction by
leukotriene B receptors of increases in cytosolic calcium in human
polymorphonuclear leukocytes. J Immunol 1985; 135: 525-530.
17. Bouchelouche PN, Ahnfelt-Renne I, Thomsen MK. LTD4 increases
cytosolic free calcium and inositol phosphates in human neutrophils:
inhibition by the novel LTD4 receptor antagonist, SR2640, and possible
relation to modulation of chemotaxis. Agents Actions 1990; 29: 299-307.
18. Victor M, Weiss J, Klempner MS, Elsbach P. Phospholipase Az activity in
the plasma membrane of the human polymorphonuclear leukocytes. FEBS
Lett 1981; 136: 298-300.
19. Rubin RP. Calcium-phosphatidylinositol interactions in secretory cells and
the role of arachidonic acid. In: Bleasdale JE, Eichberg J, Hauser G, eds.
Inositol and Pbospboinositides: Metabolism and Regulation. Clifton, NJ: Humana
Press, 1985; 367-387.
20. Goldman DW. Regulation of the receptor system for leukotriene B
human neutrophils. Ann NYA cad Sci 1988; 524: 187-195.
21. Katoh N, Raynor RL, Wise BC, et aL Inhibition by melittin of
phospholipid-sensitive and calmodulin-sensitive Caz+ dependent protein
kinases. Biochem J 1982; 202: 217-224.
22. McPhail LC, Clayton CC, Snyderman R. A potential second messenger role
for unsaturated fatty acids: activation of calcium-dependent protein kinases.
Science 1984; 224: 622-624.
23. Turner RS, Kuo JF. Phospholipid-sensitive Ca2+-dependent protein kinase
(protein kinase C): the enzyme, substrates, and regulation. In: Kuo JF, ed.
Phospholipids and Cellular Regulation, Volume II. Boca Raton, FL: CRC Press,
Inc., 1985; 90-95.
ACKNOWLEDGEMENTS. The authors grateful to Birgit Dejbjerg, Helma
Furhauge, and Hanne Kargaard for excellent technical assistance. This work
supported by handelsgartner Ove Villiam Buhl Olesen’s and aegtethelle Edith
Buhl Olesen’s Foundation, Jacob Madsen’s and hustru Olga Madsen’s
Foundation, and the Danish Medical Research Council.
Received 4 Ju ly 1992"
accepted in revised form 24 July 1992
Mediators of Inflammation. Vol 1992 317